id: https://openalex.org/W3009723094
doi: https://doi.org/10.1002/ddr.21656
title: "Angiotensin receptor blockers as tentative SARS\u2010CoV\u20102 therapeutics"
publication_date: '2020-03-04'
publication_year: 2020
cited_by_count: 828
citation_percentile: 0.999954
pagerank: 2.954855731715103e-06
authorships:
- author_id: https://openalex.org/A5081024990
  display_name: David Gurwitz
  orcid: https://orcid.org/0000-0002-9363-1869
  author_position: first
  institutions:
  - id: https://openalex.org/I16391192
    display_name: Tel Aviv University
    ror: https://ror.org/04mhzgx49
    country_code: IL
    type: funder
  is_corresponding: true
  raw_affiliation_strings:
  - Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine,
    Tel-Aviv University, Tel-Aviv, Israel
referenced_works:
- https://openalex.org/W1964982019
- https://openalex.org/W1966238900
- https://openalex.org/W1984771492
- https://openalex.org/W1985291129
- https://openalex.org/W1993577573
- https://openalex.org/W2004840558
- https://openalex.org/W2012289331
- https://openalex.org/W2048823010
- https://openalex.org/W2054429316
- https://openalex.org/W2086960330
- https://openalex.org/W2091671824
- https://openalex.org/W2095633747
- https://openalex.org/W2107435314
- https://openalex.org/W2122607820
- https://openalex.org/W2123906295
- https://openalex.org/W2132465034
- https://openalex.org/W2141108790
- https://openalex.org/W2470646526
- https://openalex.org/W2619617218
- https://openalex.org/W2938654265
- https://openalex.org/W2942776405
- https://openalex.org/W3004114601
- https://openalex.org/W3004318991
- https://openalex.org/W3004348779
- https://openalex.org/W3004775012
- https://openalex.org/W3004894342
- https://openalex.org/W3006039930
- https://openalex.org/W3006252254
- https://openalex.org/W3006394629
- https://openalex.org/W3006594788
- https://openalex.org/W3006971152
- https://openalex.org/W3007446911
- https://openalex.org/W3008763357
primary_topic: SARS-CoV-2 and COVID-19 Research
open_access: true
